Clinical Trials Browser

Interventional × Her2-Positive Breast Cancer × pertuzumab × Clear all

NCT01855828 2020-03-31

Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer

Phase 2 Completed

50 enrolled 13 charts

Her2-Positive Breast Cancer